ReviewJournal of clinical medicine2022

Bruton's Tyrosine Kinase Inhibitors: The Next Frontier of B-Cell-Targeted Therapies for Cancer, Autoimmune Disorders, and Multiple Sclerosis.

Neeta Garg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.